Showing results (141-150 of 343) with videos related to
Sort By:
Pageof 35
Current Neuropharmacology|July 7, 2025
In vivo Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple SclerosisChiara Finocchiaro, Clara Grazia Chisari, Salvatore Lo Fermo, et al.Journal of Clinical Medicine|March 25, 2022
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic SyndromesCalogero Vetro, Valeria Di Giacomo, Donato Mannina, et al.Infectious Agents and Cancer|June 25, 2016
Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in ItalyMartina Taborelli, Jerry Polesel, Maurizio Montella, et al.Journal of Hematology & Oncology|March 18, 2016
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphomaGiorgio La Nasa, Marianna Greco, Roberto Littera, et al.Leukemia Research|November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzleConcetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.Leukemia Research|June 10, 2015
miR-155 regulative network in FLT3 mutated acute myeloid leukemiaDomenico Salemi, Giuseppe Cammarata, Cecilia Agueli, et al.Frontiers in Pharmacology|July 19, 2021
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 TranscriptsMichele Massimino, Elena Tirrò, Stefania Stella, et al.International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.Frontiers in Immunology|October 9, 2023
Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experienceAndrea Duminuco, Uros Markovic, Nunziatina Laura Parrinello, et al.Molecular Neurobiology|June 28, 2018
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to CarfilzomibIgnazio Barbagallo, Cesarina Giallongo, Giovanni Li Volti, et al.Pageof 35